Mira Pharmaceuticals (MIRA) Current Assets (2022 - 2025)

Mira Pharmaceuticals has disclosed Current Assets across 4 years of filings, most recently posting $11.1 million for Q4 2025.

• Current Assets for Q4 2025 came in at $11.1 million, up 282.95% year-over-year; the trailing twelve-month figure through Dec 2025 was $11.1 million (up 282.95% YoY), and the FY2025 annual result was $11.1 million, up 282.95% from the prior year.
• Current Assets came in at $11.1 million for Q4 2025 at Mira Pharmaceuticals, up from $7.6 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $11.1 million in Q4 2025 to a low of $420719.0 in Q2 2023.
• The 4-year median for Current Assets is $3.7 million (2024), against an average of $4.0 million.
• Across the five-year window, Current Assets jumped 882.64% in 2023 and sank 63.25% in 2025, its largest moves.
• Mira Pharmaceuticals' Current Assets stood at $494405.0 in 2022, then surged by 882.64% to $4.9 million in 2023, then tumbled by 40.56% to $2.9 million in 2024, then jumped by 282.95% to $11.1 million in 2025.
• The last three Current Assets figures came in at $11.1 million (Q4 2025), $7.6 million (Q3 2025), and $832879.0 (Q2 2025), per Business Quant data.